Benjamin F. Edwards & Company Inc. Sells 645 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Benjamin F. Edwards & Company Inc. decreased its position in shares of HealthEquity, Inc. (NASDAQ:HQYGet Rating) by 44.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 799 shares of the company’s stock after selling 645 shares during the quarter. Benjamin F. Edwards & Company Inc.’s holdings in HealthEquity were worth $54,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. IndexIQ Advisors LLC bought a new position in HealthEquity in the fourth quarter valued at approximately $27,000. Pinebridge Investments L.P. bought a new position in HealthEquity in the fourth quarter valued at approximately $31,000. Signaturefd LLC lifted its stake in HealthEquity by 44.3% in the first quarter. Signaturefd LLC now owns 954 shares of the company’s stock valued at $64,000 after buying an additional 293 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its stake in HealthEquity by 30.0% in the first quarter. Steward Partners Investment Advisory LLC now owns 1,371 shares of the company’s stock valued at $92,000 after buying an additional 316 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main bought a new position in HealthEquity in the fourth quarter valued at approximately $68,000. Institutional investors own 97.44% of the company’s stock.

HealthEquity Price Performance

HealthEquity stock opened at $57.05 on Tuesday. The company has a market capitalization of $4.81 billion, a P/E ratio of -86.44, a P/E/G ratio of 4.31 and a beta of 0.97. The business has a 50 day moving average of $62.24 and a 200-day moving average of $59.87. HealthEquity, Inc. has a 1 year low of $36.81 and a 1 year high of $75.39.

HealthEquity (NASDAQ:HQYGet Rating) last posted its quarterly earnings results on Monday, June 6th. The company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.11 by $0.04. The firm had revenue of $205.68 million for the quarter, compared to analysts’ expectations of $202.72 million. HealthEquity had a positive return on equity of 3.03% and a negative net margin of 7.11%. During the same period in the prior year, the business earned $0.25 EPS. Equities analysts anticipate that HealthEquity, Inc. will post 0.66 EPS for the current year.

Wall Street Analysts Forecast Growth

HQY has been the topic of a number of research reports. Barrington Research lifted their price target on shares of HealthEquity from $70.00 to $75.00 in a research note on Tuesday, June 7th. The Goldman Sachs Group began coverage on shares of HealthEquity in a report on Tuesday, July 12th. They issued a “sell” rating and a $59.00 price objective on the stock. SVB Leerink lifted their price objective on shares of HealthEquity from $67.00 to $76.00 and gave the company an “outperform” rating in a report on Tuesday, June 7th. Wells Fargo & Company began coverage on shares of HealthEquity in a report on Monday, April 11th. They issued an “overweight” rating and a $95.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on shares of HealthEquity from $66.00 to $67.00 in a report on Wednesday, June 8th. Two investment analysts have rated the stock with a sell rating and ten have issued a buy rating to the company. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and a consensus target price of $74.33.

Insider Buying and Selling at HealthEquity

In related news, COO Edward Bloomberg sold 1,500 shares of HealthEquity stock in a transaction dated Thursday, June 9th. The stock was sold at an average price of $63.31, for a total value of $94,965.00. Following the completion of the sale, the chief operating officer now owns 60,850 shares of the company’s stock, valued at approximately $3,852,413.50. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 2.80% of the company’s stock.

About HealthEquity

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQYGet Rating).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.